Abstract: How to establish control design methods for learning systems that are subjected to the stochastic uncertainties becomes a topic of practical importance in the control field. This paper deals ...

Abstract: Model Predictive Control lacks the ability to escape local minima in nonconvex problems. Furthermore, in fast-changing, uncertain environments, the conventional warmstart, using the optimal ...

VINCENNES — The Knox County Parks and Recreation Board met Wednesday evening and motioned to continue with plans to help control invasive plant species in county parks. Within the commissioner’s ...

Johnson Controls International plc (NYSE:JCI) reported a leadership transition in its Americas business segment, according to a press release statement filed with the Securities and Exchange ...

MILWAUKEE, Sept. 24, 2025 /PRNewswire/ — Johnson Controls (NYSE: JCI), the global leader in smart, safe, healthy and sustainable buildings, has been named to Fortune’s 2025 Change the World list for ...

University departments, entities, and organizations may conduct raffles to raise funds in support of university-related activities in accordance with this policy. The University at Buffalo (UB, ...

For the past 30 years, turn on the television and, at some point, you’ve likely encountered an “ask your doctor” ad. They’re the ones that look to sell you medications and often depict very ...

If we were to look at Nifty as an indicator of market movement for the last 4 months, a small 4% range defines the entire 4 months. However, this does not mean that the index did not move. There have ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

MURFREESBORO, Tenn. (WKRN) — Murfreesboro City Council is moving forward with next steps for a proposed air traffic control tower at their local airport. On Thursday night, city council approved plans ...

Celltrion’s Omlyclo™, the first and only omalizumab biosimilar in Europe, will be commercially available starting in Norway, with subsequent rollouts in European countries Results from the global ...